Business Segments · R&D
Sleep And Breathing Health — R&D
ResMed Sleep And Breathing Health — R&D increased by 4.3% to $56.41M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from $47.24M to $56.41M. Over 2 years (FY 2023 to FY 2025), Sleep And Breathing Health — R&D shows an upward trend with a 5.8% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ3 2022
Last reportedQ1 2026
Rolls up toR&D
How to read this metric
Higher spending indicates a focus on future innovation and market leadership, whereas lower spending might signal a mature product cycle or cost-cutting.
Detailed definition
Refers to the expenditures dedicated to innovation, product design, and clinical trials specifically for the Sleep and B...
Peer comparison
Standard R&D expense metric used across the medical device and pharmaceutical industries.
Metric ID:
rmd_segment_sleep_and_breathing_health_research_and_developmentHistorical Data
15 periods
| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $43.85M | $43.85M | $43.85M | $43.85M | $46.62M | $46.62M | $46.62M | $46.62M | $47.90M | $50.07M | $47.24M | $51.14M | $50.90M | $54.10M | $56.41M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.3% | +0.0% | +0.0% | +0.0% | +2.8% | +4.5% | -5.7% | +8.3% | -0.5% | +6.3% | +4.3% |
| YoY Change | — | — | — | — | +6.3% | +6.3% | +6.3% | +6.3% | +2.8% | +7.4% | +1.3% | +9.7% | +6.3% | +8.0% | +19.4% |
Range$43.85M – $56.41M
CAGR+7.5%
Avg YoY Growth+7.3%
Median YoY Growth+6.3%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's sleep and breathing health — r&d?
- ResMed (RMD) reported sleep and breathing health — r&d of $56.41M in Q1 2026.
- How has ResMed's sleep and breathing health — r&d changed year-over-year?
- ResMed's sleep and breathing health — r&d increased by 19.4% year-over-year, from $47.24M to $56.41M.
- What is the long-term trend for ResMed's sleep and breathing health — r&d?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — r&d has grown at a 5.8% compound annual growth rate (CAGR), from $175.39M to $196.34M.
- What does sleep and breathing health — r&d mean?
- The amount spent on developing new products and improving existing technologies within the Sleep and Breathing Health segment.